Auro Laboratories

Auro Laboratories is an India-based pharmaceutical company that specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), particularly for the treatment of diabetes. Founded in 1989 and headquartered in Mumbai, the company has established itself as a significant producer of Metformin Hydrochloride, supplying both domestic and international markets. Its manufacturing facility, located in Boisar, Maharashtra, is designed to comply with Good Manufacturing Practices (GMP) to ensure high-quality standards. The company's product portfolio also includes other anti-diabetic agents like Glibenclamide and Glimepiride, alongside various drug intermediates. Auro Laboratories is publicly traded on the Bombay Stock Exchange and continues to focus on cost-effective chemical synthesis and process optimization. It primarily serves pharmaceutical formulation companies by providing the essential raw materials needed for generic drug production.